Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.36 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.36 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.36 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.36 |
| ▸ | PRKAG3 | Q9UGI9 | 1/20 | 0.36 |
| ▸ | PRKAG2 | Q9UGJ0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29503797 | 0.98 | LMNA (0.50) | LMNAHSD11B1NPSR1AKR1C1HDAC4 | |
| Hydrochloric Acid SCHEMBL6503013 | 0.98 | LMNA (0.50) | LMNAHSD11B1NPSR1AKR1C1HDAC4 | |
| SCHEMBL89807 | 0.98 | LMNA (0.51) | LMNAHSD11B1NPSR1AKR1C1HDAC4 | |
| SCHEMBL10002396 | 0.94 | LMNA (0.47) | LMNAHSD11B1NPSR1AKR1C1HDAC4 | |
| SCHEMBL5200961 | 0.90 | HSD11B1 (0.46) | LMNAHSD11B1NPSR1AKR1C1OPRM1 | |
| Hydrochloric Acid SCHEMBL6504195 | 0.89 | HSD11B1 (0.45) | LMNAHSD11B1NPSR1AKR1C1OPRM1 | |
| SCHEMBL25422745 | 0.84 | ALOX5 (0.45) | LMNAHSD11B1NPSR1AKR1C1ALOX5 | |
| SCHEMBL29514621 | 0.83 | AKR1C1 (0.66) | LMNAHSD11B1NPSR1AKR1C1HDAC4 | |
| SCHEMBL8636689 | 0.82 | OPRM1 (0.41) | LMNAHSD11B1NPSR1OPRM1OPRL1 | |
| SCHEMBL4827944 | 0.81 | AKR1C1 (0.68) | LMNAHSD11B1NPSR1AKR1C1HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4168536-A1 | METHODS AND COMPOSITIONS FOR CULTIVATING PLURIPOTENT CELL SUSPENSIONS | Life Technologies Corporation (US) | 2023-04-26 | — | — | EP | claimed |
| US-20220145266-A1 | METHODS RELATING TO INTESTINAL ORGAN-ON-A-CHIP | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-05-12 | — | — | US | disclosed |
| EP-3987006-A1 | CELL CULTURE | Agency For Science, Technology And Research (SG) | 2022-04-27 | — | — | EP | disclosed |
| WO-2020256637-A1 | CELL CULTURE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-12-24 | — | — | WO | disclosed |
| EP-2938724-A1 | CULTURING OF HUMAN EMBRYONIC STEM CELLS AT THE AIR-LIQUID INTERFACE FOR DIFFERENTIATION INTO PANCREATIC ENDOCRINE CELLS | Janssen Biotech, Inc. (US) | 2015-11-04 | — | — | EP | disclosed |
| WO-2014105543-A1 | CULTURING OF HUMAN EMBRYONIC STEM CELLS AT THE AIR-LIQUID INTERFACE FOR DIFFERENTIATION INTO PANCREATIC ENDOCRINE CELLS | JANSSEN BIOTECH, INC. (US) | 2014-07-03 | — | — | WO | disclosed |
| CN-100422160-C | Morpholine derivatives, process for their preparation and pharmaceutical compositions containing them | SANOFI SYNTHELABO (FR) | 2008-10-01 | — | — | CN | disclosed |
| EP-1150970-B1 | (1-PHENACY-3-PHENYL-3-PIPERIDYLETHYL)PIPERIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | SANOFI AVENTIS (FR) | 2007-08-22 | — | — | EP | disclosed |
| EP-1165528-B1 | NOVEL MORPHOLINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID DERIVATIVES | SANOFI SYNTHELABO (FR) | 2004-09-01 | — | — | EP | disclosed |
| CN-1353698-A | Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives | SANOFI SYNTHELABO (FR) | 2002-06-12 | — | — | CN | disclosed |
| EP-1165528-A1 | NOVEL MORPHOLINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID DERIVATIVES | SANOFI-SYNTHELABO (FR) | 2002-01-02 | — | — | EP | disclosed |
| EP-1150970-A1 | (1-PHENACY-3-PHENYL-3-PIPERIDYLETHYL)PIPERIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | Sanofi-Aventis (FR) | 2001-11-07 | — | — | EP | disclosed |
| WO-2000058292-A1 | NOVEL MORPHOLINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID DERIVATIVES | SANOFI-SYNTHELABO (FR) | 2000-10-05 | — | — | WO | disclosed |
| WO-2000047572-A1 | (1-PHENACY-3-PHENYL-3-PIPERIDYLETHYL)PIPERIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | SANOFI-SYNTHELABO (FR) | 2000-08-17 | — | — | WO | disclosed |